Figure 2.
Notification rates of confirmed cases* (N/100,000) from 1999† to 2019 by country and by serogroup. BE, Belgium; DE, Germany; ES, Spain; FR, France; IT, Italy; NL, Netherlands; PT, Portugal; UK, United Kingdom. *Confirmed case of IMD is defined as any person meeting at least one of the following laboratory criteria: isolation of N. meningitidis from a normally sterile site, or purpuric skin lesions; detection of N. meningitidis nucleic acid from a normally sterile site, or purpuric skin lesions; detection of N. meningitidis antigen in cerebrospinal fluid; detection of Gram-negative stained diplococcus in cerebrospinal fluid. †No data for PT in 1999. Arrows indicate vaccination introduction; pattern fills indicate the country introducing vaccination in its vaccination program.
